Boiron S.A. | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 576.3M
Total Liabilities 198.1M
Shareholders Equity 378.2M
Debt to Equity 0.52

Cash Flow Metrics

Revenue & Profitability Trend

Boiron S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i487.6M493.2M534.2M455.2M513.6M
Cost of Goods Sold i128.8M135.2M154.5M127.6M118.8M
Gross Profit i358.8M358.1M379.7M327.6M394.7M
Gross Margin % i73.6%72.6%71.1%72.0%76.9%
Operating Expenses
Research & Development i6.3M5.8M6.1M3.0M3.5M
Selling, General & Administrative i238.3M232.8M236.9M212.8M244.3M
Other Operating Expenses i78.4M79.3M80.1M73.1M77.2M
Total Operating Expenses i322.9M317.9M323.1M288.9M325.0M
Operating Income i35.8M40.8M56.6M39.5M69.7M
Operating Margin % i7.3%8.3%10.6%8.7%13.6%
Non-Operating Items
Interest Income i2.9M7.5M1.8M590.0K459.0K
Interest Expense i1.2M1.2M607.0K359.0K348.0K
Other Non-Operating Income-----
Pre-tax Income i14.6M46.9M59.2M46.1M37.2M
Income Tax i3.2M12.9M14.9M17.6M11.0M
Effective Tax Rate % i22.2%27.6%25.2%38.1%29.6%
Net Income i11.3M33.9M44.3M28.6M26.2M
Net Margin % i2.3%6.9%8.3%6.3%5.1%
Key Metrics
EBITDA i79.9M65.3M70.0M59.5M136.0M
EPS (Basic) i-€2.06€2.57€1.63€1.50
EPS (Diluted) i-€2.06€2.57€1.63€1.50
Basic Shares Outstanding i-17362222173891711751646817508151
Diluted Shares Outstanding i-17362222173891711751646817508151

Income Statement Trend

Boiron S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i64.7M74.0M250.9M234.5M234.7M
Short-term Investments i-----
Accounts Receivable i89.9M87.0M100.5M97.3M88.9M
Inventory i101.1M96.8M96.9M85.6M85.0M
Other Current Assets19.2M24.3M26.3M29.8M329.0K
Total Current Assets i281.0M286.2M477.8M452.4M441.5M
Non-Current Assets
Property, Plant & Equipment i186.3M29.3M28.7M194.7M196.7M
Goodwill i208.8M209.5M219.9M210.3M209.2M
Intangible Assets i29.3M30.1M31.9M31.0M30.1M
Long-term Investments-----
Other Non-Current Assets52.0K85.0K39.0K41.0K32.0K
Total Non-Current Assets i295.3M304.0M311.7M318.3M340.4M
Total Assets i576.3M590.2M789.5M770.7M781.8M
Liabilities
Current Liabilities
Accounts Payable i37.2M44.6M48.2M44.2M38.2M
Short-term Debt i4.5M7.1M5.4M4.9M3.5M
Current Portion of Long-term Debt-----
Other Current Liabilities3.7M3.9M4.3M--
Total Current Liabilities i111.8M126.3M153.2M158.2M176.5M
Non-Current Liabilities
Long-term Debt i10.5M6.6M16.7M7.7M8.9M
Deferred Tax Liabilities i000-0
Other Non-Current Liabilities-----
Total Non-Current Liabilities i86.3M72.4M79.0M80.7M96.1M
Total Liabilities i198.1M198.7M232.1M238.9M272.7M
Equity
Common Stock i17.5M17.5M17.5M17.5M17.5M
Retained Earnings i--460.2M434.3M411.7M
Treasury Stock i7.4M7.4M7.0M--
Other Equity-----
Total Shareholders Equity i378.2M391.5M557.3M531.8M509.2M
Key Metrics
Total Debt i15.0M13.7M22.2M12.6M12.4M
Working Capital i169.2M159.9M324.6M294.1M264.9M

Balance Sheet Composition

Boiron S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i11.3M35.8M44.7M28.6M26.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-1.2M7.7M6.9M-23.0M-15.3M
Operating Cash Flow i8.5M24.9M40.0M-3.0M9.5M
Investing Activities
Capital Expenditures i-8.4M-7.6M-2.7M-648.0K-9.0M
Acquisitions i-977.0K0-1.7M--53.0K
Investment Purchases i-2.2M-7.2M-3.0M-1.9M-453.0K
Investment Sales i736.0K89.0K439.0K84.0K94.0K
Investing Cash Flow i-10.8M-14.8M-6.9M-2.5M-9.4M
Financing Activities
Share Repurchases i-206.0K-122.0K-6.4M-12.0K-4.0K
Dividends Paid i-23.4M-199.0M-16.5M-16.6M-18.4M
Debt Issuance i019.0K22.0K3.0K22.0K
Debt Repayment i-1.3M-1.0M-963.0K-1.2M-1.3M
Financing Cash Flow i-22.0M-193.2M-22.3M-17.2M-19.2M
Free Cash Flow i23.6M27.5M40.1M12.9M47.6M
Net Change in Cash i-24.4M-183.0M10.7M-22.7M-19.1M

Cash Flow Trend

Boiron S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.77
Forward P/E 10.41
Price to Book 1.04
Price to Sales 0.80
PEG Ratio 10.41

Profitability Ratios

Profit Margin 2.33%
Operating Margin 11.28%
Return on Equity 2.95%
Return on Assets 4.60%

Financial Health

Current Ratio 2.51
Debt to Equity 3.96
Beta 0.24

Per Share Data

EPS (TTM) €0.65
Book Value per Share €21.78
Revenue per Share €28.08

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
boi392.4M34.771.042.95%2.33%3.96
Ipsen S.A 9.5B21.492.2610.89%11.91%22.74
Vetoquinol S.A 887.3M15.101.5410.64%10.88%3.67
Euroapi S.A.S.U 301.9M8.840.40-13.49%-14.08%7.17
AB Science S.A 83.1M-8.60-32.97%116.42%-0.78
CoreTech Limited 3.0M---102.42%137.36%-0.95

Financial data is updated regularly. All figures are in the company's reporting currency.